Table of Contents
June 1, 2004 — Volume 109, Issue 21 suppl 1
Jump to
Vascular Effects of Statins
- You have accessRestricted accessIntroductionPeter Libby, James T. WillersonCirculation. 2004;109:II-1, originally published June 1, 2004https://doi.org/10.1161/01.CIR.0000129499.33411.59
- You have accessRestricted accessInflammation as a Cardiovascular Risk FactorJames T. Willerson, Paul M. RidkerCirculation. 2004;109:II-2-II-10, originally published June 1, 2004https://doi.org/10.1161/01.CIR.0000129535.04194.38
- You have accessRestricted accessCRP as a Mediator of DiseaseEdward T.H. YehCirculation. 2004;109:II-11-II-14, originally published June 1, 2004https://doi.org/10.1161/01.CIR.0000129507.12719.80
- You have accessRestricted accessStatins as Immunomodulatory AgentsFrançois MachCirculation. 2004;109:II-15-II-17, originally published June 1, 2004https://doi.org/10.1161/01.CIR.0000129502.10459.fe
- You have accessRestricted accessInflammation, Immunity, and HMG-CoA Reductase InhibitorsStatins as Antiinflammatory Agents?Uwe Schönbeck, Peter LibbyCirculation. 2004;109:II-18-II-26, originally published June 1, 2004https://doi.org/10.1161/01.CIR.0000129505.34151.23
- You have accessRestricted accessEndothelial FunctionA Critical Determinant in Atherosclerosis?Ulf Landmesser, Burkhard Hornig, Helmut DrexlerCirculation. 2004;109:II-27-II-33, originally published June 1, 2004https://doi.org/10.1161/01.CIR.0000129501.88485.1f
- You have accessRestricted accessEffects of HMG-CoA Reductase Inhibitors on Endothelial FunctionRole of Microdomains and Oxidative StressR. Preston Mason, Mary F. Walter, Robert F. JacobCirculation. 2004;109:II-34-II-41, originally published June 1, 2004https://doi.org/10.1161/01.CIR.0000129503.62747.03
- You have accessRestricted accessBeyond the LaboratoryClinical Implications for Statin PleiotropyJulian P.J. Halcox, John E. DeanfieldCirculation. 2004;109:II-42-II-48, originally published June 1, 2004https://doi.org/10.1161/01.CIR.0000129500.29229.92
